Prolactin and schizophrenia: Clinical consequences of hyperprolactinaemia

Life Sciences

Volumn 71, Issue 9, 2002, Pages 979-992

  Meaney, Anna Maria ^a   O'Keane, Veronica ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Bone mineral density; Prolactin; Schizophrenia

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PROLACTIN; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

AMENORRHEA; BONE DENSITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; FERTILITY; GALACTORRHEA; HORMONE ACTION; HUMAN; HYPERPROLACTINEMIA; MENTAL DISEASE; MOLECULAR BIOLOGY; OLIGOMENORRHEA; OVULATION; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; SCHIZOPHRENIA; SEXUAL DYSFUNCTION; SHORT SURVEY;

BOVINAE; COLUMBA; MAMMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0037135267     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)01775-7     Document Type: Review

References (79)

1. A Literature review of prolactin in schizophrenia
2. The prolactin gene is located on chromosome 6 in humans
3. Human pituitary prolactin: The entire amino acid sequence
4. Prolactin: Structure, function and regulation of secretion
5. Prolactin-like immunoreactivity: Localization in nerve terminals of rat hypothalamus
6. Distribution of immunoreactive prolactin in the male and female rat brain: Effects of hypophysectomy and intraventricular administration of colohicine
7. Extrahypothalamic brain pituitary: Characterization and evidence for pituitary prolactin
8. Distribution and partial characterization of immonoreactive prolactin in the rat brain
9. Serum prolactin levels during the menstrual cycle
10. The neuroendocrine control of ovarian cycle of the rat
11. Prolactin in rat hypothalamus: Autoradiographic localization and chacterization
12. Evidence that prolactin does not affect the induction of sexual behaviour by oestradiol and progesterone in ovariectomized rats
13. Inhibition of sexual behavior in lactating rats
14. Inhibition of lordosis behavior in female rat by intraventricular infusion of prolactin and by chronic hyrerprolactinaemia
15. Midbrain microinfusions of prolactin increase the estrogen dependent behavior, lordosis
16. Incresed serum prolactin levels mediate the suppressive effects of ectopic pituitary grafts on copulatory behavior in male rats
17. Thioridazine and sexual dysfunction
18. Central prolactin infusions stimulate mmaternal behavior in steroid treated nulliparous female rats
19. Prolactin, bromocriptine and autoimmune diseases
20. Regulation of water and solute transport across mammalian plasma cell membranes by prolactin
21. Effect of prolactin on Rb uptake, potassium content and [G-H] oubain binding of lactating rabbit mammary tissue
22. Possible mechanism for of prolactin on mammary cell sodium transport
23. Prolactin and fetal osmoregulation: Water transport across isolated human amnion
24. Analysis of the role of endogenous prolactin on fluid and sodium chloride absorption by rat jejunum
25. Stimulation of intestinal calcium transport and bone calcium metabolism by prolactin in vitamin D-deficient rats
26. Opposing actions of intact and N-terminal fragments of human prolactin growth hormone family members on angiogenesis: An efficient mechanism for the regulation of angiogenesis
27. Individual lactotrophs release prolactin in a temporally divergent and sexually dimorphic pattern
28. Relation of sleep-entrained human prolactin release to REM-non REM cycles
29. Gender differences in temporal organisations of prolactin secretion: Evidence for a sleep independent circadian rhythm of circulatory prolactin
30. Regulation of prolactin secretion
31. Interpreting prolactin levels: Implications for the management of large pituitary lesions
32. Management of psycotropic-induced hyperprolactinaemaia
33. Circadian changes of serum prolactin levels and tuberoinfundibular dopaminergic neuron activities in ovariectomized rats treated with or without estrogen: The role of the supra chiasmatic nuclei
34. Luteal cell receptor content for prolactin and leutinising hormone. Regulation by LH and PRL
35. Hypothalamic sites which control surges of prolactin secretion induced by cervical stimulation
36. Serum prolactin levels in lactating rats after suckling or exposure to ether
37. The influence of academic stress and season on 24-hour concentration of growth hormone and prolactin
38. Galactorrhea and hyperprolactinemia in schizophrenic patients on neuroleptics: Frequency and etiology
39. Hormonal side effects in women: Typical versus atypical anti-psychotic treatment
40. Impaired LH responsiveness to gonadotropin-releasing hormone in the inferior petrosal sinus of hyperprolactinaemic patients
41. The effects of phenothiazines on endocrine function: Patients with inappropriate lactation and amenorrhoea
42. New directions in the treatment of hyperprolactinemia
43. Immunomodulation by bromocriptine
44. Hyperprolactinaemia and sexual function
45. The importance of hyperprolactinaemia in impotence
46. Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients
47. Endocrine causes of impotence
48. Hyperprolactinaemia in males: A heterogenous disorder
49. Circadian rhythm of tryptophan, serotonin, melatonin and pituitary hormones in schizophrenia
50. Abnormal prolactin response to haloperidol challenge in men with schizophrenia
51. High plasma prolactin levels after long term neuroleptic treatment
52. Prolactin secretion in patients with various drugs. Phenothiazines, tricyclic antidepressants, reserpine and methyldopa
53. Slow decline of plasma drug and prolactin levels after discontinuation of chronic treatment with depot neuroleptics
54. Tolerance to prolactin secretion in the long term treatment with neuroleptics in Schizopphrenia
55. Effect of clozapine levels
56. Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients
57. Risperidone in the treatment of schizophrenia
58. Status report: Ziprasidone
59. ICI 204, 636, an atypical anti-psychotic: Efficacy and safety in a multi centre trial, placebo controlled trial in patients with schizophrenia
60. Galactorrhea and hyperprolactinaemia
61. Increase in bone mass after treatment of hyperprolactinaemic amenorrhea
62. Neuroleptics and sexual functioning
63. Sexual dysfunction in male schizophrenic patients
64. A survey of psychosexual arousability in male patients on depot neuroleptic medication
65. Effects of psychotropic drugs on human erection and ejaculation
66. Clozapine versus typical anti-psychotics. A retro- and prospective study of extra pyramidal side effects
67. Subjective utility ratings of neuroleptics in treating schizophrenia
68. Circulating nitric oxide levels in galactorrheic, hyperprolactinemic, amenorrhoeic women
69. Prevalence and magnitude of Osteopenia in patients with prolactinoma
70. Osteoporosis in men with hyperprolactinaemic hypogonadism
71. Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women
72. Effects of prolactin and estrogen deficiency in amenorrheic bone loss
73. Decreased bone mineral density in medicated psychiatric patients
74. Menopause and heart disease: A review
75. Psychopathology in men and women: Focus on female hormones
76. Ovarian steroids and the brain: Implications for cognition and aging